CDCA7L and cancer: In addition, we report several novel gene combinations (H1: CDCA7L-MLLT3, P3: SND1-TMEM178B), of which individual fusion partners have been previously reported in the context of several cancers, including MLLT3 in leukemia [54], SND1 (staphylococcal nuclease and tudor domain) in lung cancer [55,56].